Related Experiment Video
Updated: Jun 3, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
[Obesity-related hypertension]
Jannick A N Dorresteijn1, Frank L J Visseren, A H van den Meiracker
1Universitair Medisch Centrum Utrecht, Afd. Vasculaire Geneeskunde, The Netherlands.
Insights
Obesity-related hypertension is common and hard to treat with drugs. Lifestyle changes like weight loss and reduced salt intake are key, as some medications increase diabetes risk.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Metabolic Disease
Context:
- Hypertension affects over 40% of obese adults, increasing cardiovascular disease risk.
- Obesity-related hypertension is frequently resistant to pharmacological control.
- Shared risk factors and etiological links connect obesity and hypertension.
Purpose:
- To explain the mechanisms linking obesity to hypertension.
- To highlight the challenges in treating obesity-related hypertension.
- To emphasize the importance of lifestyle modifications.
Summary:
- Obesity can cause dysfunctional adipose tissue, leading to hormonal imbalances (adipokines).
- This triggers sympathoactivation, renin-angiotensin-aldosterone system (RAAS) upregulation, inflammation, and oxidative stress.
- These factors cause vascular resistance and increased blood volume, resulting in drug-resistant hypertension.
Impact:
- Lifestyle modifications, including weight reduction and salt restriction, are primary treatments.
- Certain medications (beta-blockers, diuretics) may increase the risk of developing new-onset diabetes mellitus.
- Understanding these mechanisms can guide more effective therapeutic strategies for obesity-related hypertension.
Abstract:
Hypertension occurs in more than 40% of obese adults and leads to increased risk for cardiovascular disease and death. In practice, obesity-related hypertension is often difficult to control with pharmacological treatment. The association of obesity and hypertension can partly be explained by mutual risk factors, but there is also an etiological relation. Increasing obesity may lead to dysfunctional adipose tissue, characterised e.g. by deranged production of hormones and cytokines (adipokines). This results in sympathoactivation, upregulation of the renin-angiotensin-aldosterone system (RAAS) and systemic low grade inflammation and oxidative stress. The common result of these deregulations is increased resistance of the peripheral vasculature due to endothelial dysfunction, vasoconstriction and vascular wall hypertrophy, and increased circulating volume due to impaired pressure natriuresis. This leads to the development of hypertension that is relatively resistant to drug therapy. Lifestyle modifications by means of weight reduction and salt restricted diet are the cornerstones of obesity-related hypertension treatment. Pharmacological treatment with beta-blockers or diuretics is not self-evident, since this increases the risk of developing de novo diabetes mellitus.
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Obesity
Drug Dosing: Obese Patients
Hypertension III: Clinical Manifestations and Diagnostic Studies